Correct Answer : Option (D) - AstraZeneca-Oxford Vacccine
Guillain-Barre Syndrome is a rare neurological disorder, in which the body’s immune system attacks its own protective coatings on nerve fibres.
This syndrome was first reported in Europe and the UK among some patients who undertook AstraZeneca-Oxford Covid-19 vaccine, but such a probability is found to be small. The syndrome may start with extreme weakness that can eventually paralyse the entire body. The vaccine is traded as Covishield in India, which also reported some cases.